Fj. Martin et al., EFFECTS OF STREPTOZOTOCIN-INDUCED EXPERIMENTAL DIABETES AND INSULIN THERAPY ON PLATELET SEROTONIN UPTAKE AND VOLUME, Biogenic amines, 11(1), 1995, pp. 77-85
Platelet serotonin uptake and mean platelet volume were measured in bo
th healthy control and streptozotocin-induced diabetic rats with or wi
thout insulin treatment. The values of K-m and V-max were similar in a
ll groups studied, and the individual values were unrelated to glycaem
ia and mean platelet volume. The platelet size in the diabetic+insulin
group (4.82+/-0.12 fl; mean+/-SEM) and control group (4.78+/-0.08) wa
s comparable, being higher in the diabetic group (5.22+/-0.13), and lo
wer in the non-diabetic+insulin group (4.54+/-0.05) when compared with
the control group. Plasma glucose levels were significantly correlate
d to mean platelet volume only in the diabetic+insulin group. We concl
ude that changes in platelet size in diabetes appear to be an effect o
f the lack of insulin. The data neither discards nor confirms that var
iations in the kinetics of platelet serotonin uptake contribute to the
minor platelet amine contents in diabetic animals.